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In patients with hyperdynamic hemodynamics, infusing arginine vasopressin (AVP)
in advanced vasodilatory shock is usually accompanied by a decrease in cardiac
output and in visceral organ blood flow. Depending on the infusion rate, this
vasoconstriction also reduces coronary blood flow despite an increased coronary
perfusion pressure. In a porcine model of transitory myocardial ischemia-induced
left ventricular dysfunction, Müller and colleagues now report that the AVP-related
coronary vaso-constriction may impede diastolic relaxation while systolic
contraction remains unaffected. Although any AVP-induced myocardial ischemia
undoubtedly is a crucial safety issue, these findings need to be discussed in the
context of the model design, the dosing of AVP as well as the complex direct,
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